Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Isildar AA et al. | 2005 | soil | magnetic field, 50/60 Hz, power transmission line | 14.9–673.7 mA/m |
| Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) | magnetic field, 50/60 Hz | 16 mT |
| Lorimore SA et al. | 1990 | animal, mouse/CBA/H | magnetic field, 50/60 Hz | 20 mT |
| Huang L et al. | 2006 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) and SK-Hep-1 (hepatocellular carcinoma cells) | magnetic field, 50/60 Hz | 20 mT |
| Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
| Aksyonov SI et al. | 2007 | plant, wheat seed (<i>Triticum aestivum</i> L.), different cultivars (Zarya, Inna, Mironovskaya 808) | magnetic field, low frequency, 50/60 Hz | 30 mT |
| Scaiano JC et al. | 1995 | isolated bio./chem. substance, benzophenone ketyl-cyclohexadienyl radical pairs in sodium dodecyl sulfate (SDS) micelles | magnetic field, 50/60 Hz, DC, static magnetic field | 34–140 mT |
| Radeva M et al. | 2004 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) and DG75 cells (human Burkitt's lymphoma cell line) and HL-60 cells (human promyelocytic leukemia cell line) | magnetic field, 50/60 Hz, co-exposure | 35 mT |
| Ikehara T et al. | 2003 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) | magnetic field, 50/60 Hz | 43.6 mT |
| Juszczak K et al. | 2012 | intact cell/cell culture, urothelial cells (primary culture from urinary bladders of female Wistar rats) | magnetic field, signals/pulses, 50/60 Hz, electrotherapy | 45 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
